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The Association of Changes in Local Health Department Resources With
Changes in State-Level Health Outcomes
Paul Campbell Erwin, MD, DrPH, Sandra B. Greene, DrPH, Glen P. Mays, PhD, MPH, Thomas C. Ricketts, PhD, MPH, and Mary V. Davis, DrPH, MSPH
We explored the associa-
tion between changes in local
health department (LHD) re-
source levels with changes in
health outcomes via a retro-
spective cohort study.
We measured changes in
expenditures and staffing
reported by LHDs on the
1997 and 2005 National Asso-
ciation of County and City
Health Officials surveys and
assessed changes in state-
level health outcomes with
the America’s Health Rankings
reports for those years. We
used pairwise correlation and
multivariate regression to ana-
lyze the association of changes
in LHD resources with changes
in health outcomes.
Increases in LHD expendi-
tures were significantly ass-
ociated with decreases in
infectious disease morbidity at
the state level (P=.037), and




trolling for other factors. (Am
J Public Health. 2011;101:609–
615. doi:10.2105/AJPH.2009.
177451)
THE ULTIMATE AIM OF LOCAL
health departments (LHDs) is to
improve the quality of life for the
communities they serve—a part of
the larger mission of public health,
which is ‘‘the fulfillment of soci-
ety’s interest in assuring the con-
ditions in which people can be
healthy.’’1(p7) Since the Institute of
Medicine’s 1988 report, The Future
of Public Health, there have been
numerous studies that have described
and measured the performance of
LHDs, the characteristics associ-
ated with performance, and
whether and how such performance
affects health.2 Studies have most
often described associations of per-
formance with LHD size, jurisdic-
tional size, and funding: LHDs with
larger staffs, serving populations
greater than 50000 persons, and
with higher funding per capita were
more often higher performing.3–14
Higher performing LHDs also had
greater community interaction, a di-
rector with higher academic de-
grees, and leadership functioning
within a management team.5,9,11,15
Only 4 published studies have
attempted to link LHD character-
istics, activities, or performance to
health outcomes.9,13,16,17 All of
these studies are limited by their
cross-sectional design. One study
has examined the longitudinal
relationship between LHD inputs
and health outcomes, showing
significant associations between
changes in local public health
spending and infant mortality and
deaths attributable to cardiovascu-
lar disease (CVD), diabetes, and
cancer at the county level.18
We focused on the relation-
ship between changes in LHD
inputs (financial resources, staff-
ing), aggregated to the state, and
changes in state-level health
measures (smoking and obesity
prevalence, infectious disease
morbidity, infant mortality, can-
cer and CVD mortality, and pre-
mature death). Aggregating LHD
inputs to a state level not only
allows the opportunity to explore
the impact of LHDs’ combined
resources but also reduces the
complexities inherent in studies
Publisher’s Note: During the copyediting process, reference #38 in the above article was changed and erroneously cited the current (2008) ‘‘Standards of Excellence’’ from the National Health
Council. The authors actually used the ‘‘Guiding Principles for Voluntary Health Agencies in Corporate Relationships’’ from 1998, a document that was available online when the study was
conducted. Reference #38 has been corrected to link to the document used for the study. The National Health Council’s ‘‘Standards of Excellence’’ is the policy currently applicable to, among other
things, the issues discussed by the authors. The policy articulates different standards of transparency for health advocacy organizations than the document used by the authors. It can be viewed at http://
www.nationalhealthcouncil.org/forms/soe.pdf.
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that have compared LHDs to one
another, always a challenging
task with the very large differ-
ences in LHD size, functions, and
jurisdictions.
Conceptual and logic models
pertaining to public health in gen-
eral posit that an increase in inputs
leads to enhanced capacity to pro-
vide the essential public health
services, which, in turn, leads to im-
proved public health performance
and, ultimately, to improvements
in community health status.19 The
health measures included in this
study were selected on the basis of
amenability to public health inter-
ventions for which logic models
may be specified. The primary and
secondary prevention methods that
may lead to improvements in these
health measures—e.g., community-
based efforts to enhance physical
activity opportunities to reduce CVD
and targeted immunization cam-
paigns to reduce vaccine-preventable
diseases20—are interventions that
are commonly led by LHDs.
The relative paucity of empiri-
cal evidence that supports such
logic models for LHDs remains
a challenge for public health. This
serves as rationale for our study,
the goal of which is to identify LHD
inputs that may ultimately lead to
health improvements. We investi-
gated the association between LHD
inputs—aggregated to the state—and
health outcomes at the state level.
This association has relevance both
for local public health leaders, who
are being held more accountable
for how local resources are used,
and for state leaders, who are often
challenged to show how invest-
ments at the local level can deliver
on a promise of improving state-
level health measures.
METHODS
We examined 2 data sets to
determine the extent to which
changes in LHD inputs are asso-
ciated with changes in health
measures: surveys of LHDs by
the National Association of
County and City Health Officials
(NACCHO) and America’s Health
Rankings (AHR), produced by the
United Health Foundation.
We utilized LHD expenditures,
staffing, and jurisdictional popula-
tion data from field surveys con-
ducted by NACCHO in 1997 and
2005. Completed surveys were
returned for 2492 of the 2832
(88%) identified LHDs in 1997
and 2300 of the 2864 (80%)
identified in 2005. A total of1924
LHDs reported in both 1997 and
2005.
Local health departments
reported actual total expenditures
for the most recent fiscal year
before the survey; 1997 expendi-
tures were adjusted to 2005 dol-
lars. The method of adjustment
follows the model proposed by
NACCHO and used by Mays and
Smith, with spending measures
adjusted to represent 2005 con-
stant dollars by using a weighted
average of the general Consumer
Price Index (CPI) and the medical
care CPI.18,21 Local health depart-
ments reported the total number
of full-time equivalents (FTEs)
employed by their agency. We
aggregated local health department
expenditures, FTEs, and jurisdic-
tional populations to the state level.
We calculated changes in LHD
expenditures and FTEs per capita
between 1997 and 2005 on the
basis of both proportional change
and absolute change between these
2 points in time.
We derived state-level health
measures from the AHR reports,
which have been produced annually
since1990.22 We included 7 health
measures in this study: smoking
and obesity prevalence, infectious
disease morbidity, infant mortality,
mortality from CVD and cancer,
and years of potential life lost
(YPLL). America’s Health Rankings
derives data for these health mea-
sures from other secondary sources
as described subsequently.
Smoking prevalence is a mea-
sure of the percentage of the pop-
ulation aged 18 years and older
that has smoked at least 100 ciga-
rettes and currently smokes to-
bacco products regularly. Obesity
prevalence is a measure of the
percentage of the population esti-
mated to be obese, defined as
having a body mass index of 30.0
kg/m2or higher. The source of
data for smoking and obesity is the
Behavioral Risk Factor Surveil-
lance System.23
Infectious disease morbidity in-
cludes the 3-year average occur-
rences of AIDS, tuberculosis, and
hepatitis (A and B), as representa-
tive of all infectious diseases, per
100000 population, as reported
by state health departments in the
Morbidity and Mortality Weekly
Report from the Centers for Dis-
ease Control and Prevention
(CDC).
Infant mortality is the rate of
infant deaths per 1000 live births
in a year. Cardiovascular deaths
were measured by using a 3-year
average, age-adjusted death rate
(per 100000 population) attribut-
able to heart disease, strokes, and
other forms of CVD. Cancer
deaths were measured by using
a 3-year average, age-adjusted
death rate (per 100000 popula-
tion) attributable to cancer. YPLL
measures the loss of productive
life because of death before age
75 years. The source of data for
these measures of mortality was
the US National Center for Health
Statistics.24
Data Management
To improve comparability be-
tween the 1997 and 2005 data,
we only included the 1924 LHDs
that reported in both surveys in
the initial data set. We removed
LHDs that did not report expen-
diture data for both years, reduc-
ing the data set to 1852 LHDs in
1997 and 1856 LHDs in 2005.
Four states were excluded: Rhode
Island, because it has no LHDs;
Hawaii and Alaska, because they
both had only 1 LHD report ex-
penditure for 2005 and no
reported expenditures for 1997;
and Mississippi, because the state
reported by county-level LHDs in
1997 and multicounty districts in
2005.
We aggregated LHDs’ jurisdic-
tional populations by state. We
excluded states that had less than
40% of their actual total popula-
tion represented, for either 1997
or 2005, from further data analy-
sis. This removed an additional 4
states: Maine, New Hampshire,
New Mexico, and South Dakota.
The final data set included data
from 1843 LHDs in 1997 and
1845 LHDs in 2005, covering 42
states, with a 97% match for
LHDs with usable data for both
1997 and 2005. For the 42 states
that were retained, the actual state
population represented in 1997
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ranged from 40.8% to 96.5%,
with a mean of 78.7% and a me-
dian of 81.3%. For 2005, the
range of actual state population
represented was 40.6% to 100%,
with a mean of 83.6% and a me-
dian of 85.9%. Total aggregated
data for the 42 states represented
78.4% of the US population for
1997 and 82.9% of the US pop-
ulation in 2005.
We selected data from the
AHR reports by most closely
matching the source years of the
data for both AHR reports and
NACCHO surveys. The 1997
NACCHO survey data matched
most closely with the data in-
cluded in the 1998 AHR report,
whereas the 2005 NACCHO
survey matched most closely with
the 2008 AHR report. We de-
termined changes for each of the
7 health measures between the
1998 and 2008 AHR reports by
calculating proportional and ab-
solute changes between the 2
points in time.
Data Analysis
Changes in LHD expenditures
and staffing per capita, aggregated
to the state level, served as in-
dependent variables, and changes
in the 7 health measures from
AHR served as dependent vari-
ables. We assessed the association
between the changes in specific
dependent variables with the
changes in independent variables
with the Spearman rank correla-
tion, and with multivariate regres-
sion. To analyze data, we used
Stata version 10 (StataCorp LP,
College Station, TX). Control vari-
ables in the regression models in-
cluded factors known to influence
health at the community level:
high-school graduation (percent-
age of the population aged older
than 25 years that has graduated),
health insurance (percentage with
health insurance), poverty (per-
centage below federal poverty
line), racial composition (percent-
age of population that is non-
White), and age structure
(percentage of the population aged
older than 65 years). Data for
these control variables were for
1996 only, the primary source
year of data for variables in the
1997 NACCHO profile and the
1998 AHR report.
RESULTS
Results are presented by
changes in independent variables,
changes in dependent variables,





per capita (Table 1) fell between
1997 and 2005. Expenditures
per capita expressed in constant
dollars varied widely, ranging
from $13.40 in Vermont to
$169.30 in California in1997, and
$15.60 in New Jersey to $143.60
in New York in 2005. Twenty-
three states experienced a decline
in expenditures per capita, whereas
19 states had an increase between
1997 and 2005. Although the
overall mean proportional change
for these 42 states was a positive
2.6%, the total sum of LHD ex-
penditures per capita across all
states was 15.8% lower in 2005
than in 1997.
State-level mean FTEs per cap-
ita (Table 1) also fell between
1997 and 2005. The number of
FTEs per capita ranged from 2.31
(per10000 population) in Vermont
to 13.38 in Alabama in 1997,
and 1.53 in Arizona to 10.46 in
Maryland in 2005. Only12 states
experienced an increase in FTEs
per capita between1997 and 2005.
Changes in Dependent
Variables
The changes in the dependent
variables between the 1998 and
2008 AHR reports are shown in
Table 2. Overall, rates for all health
measures declined between 1998
and 2008, with1exception: obesity
prevalence increased. All 42 states
showed declines in infectious dis-
ease morbidity and CVD mortality,
with all but 1 state also showing
declines in smoking prevalence and
cancer mortality. Changes in infant
mortality and premature deaths
(YPLL) showed a mix of states with
declining and increasing rates, with
the majority of states still showing
a decline. Obesity prevalence in-
creased in all 42 states by a mean




With the measures of propor-
tional change, there were statistically
significant negative associations
TABLE 1—Overall 1997 and 2005 Aggregated LHD Expenditures per Capita and FTEs per Capita, and
State-Level Proportional and Absolute Changes Between 1997 and 2005: 42 US States
Variable Mean Median SD Minimuma Maximumb Composite IQR
Expenditures per capita
1997 overall $44.13 $34.24 $29.80
2005 overall $42.17 $34.30 $23.92
Proportional change, % 2.57 –1.72 27.35 –57.28 71.33 25.17
Absolute change –1.96 –0.71 21.74 –84.87 59.79 9.96
FTEs per capita (· 10 000)
1997 overall 6.12 5.73 2.66
2005 overall 5.12 4.66 1.97
Proportional change, % –11.48 –16.47 26.66 –64.22 83.76 28.02
Absolute change –1.00 –0.80 2.01 –8.12 3.95 1.74
Notes. FTE = full-time-equivalent employee; IQR = interquartile range; LHD = local health department.
aFor negative numbers, greatest decrease, 1998–2008.
bGreatest increase.
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between changes in expendi-
tures per capita and infectious
disease morbidity (r=–0.3407;
P = .0272) and CVD deaths (r=
–0.3723; P= .015) and between
FTEs per capita and CVD
deaths (r=–0.3689; P = .016;
Table 3). The correlations that
used absolute change showed
a significant inverse relationship
between FTEs per capita and
CVD deaths (r=–0.3482;
P= .024). For the majority of
these correlations, the results
were consistent in direction and
significance between using pro-
portional change and absolute
change.
Multiple Linear Regression
As shown in Table 4, an in-
crease in expenditures per capita
was statistically significantly as-
sociated with a decrease in in-
fectious diseases (t=–2.17;
P = .037). For each 10 percentage
point increase in expenditures
per capita, infectious disease
morbidity declined by 1.82 per-
centage points. An increase in
FTEs per capita was statistically
significantly associated with a de-
crease in CVD mortality (t=–2.59;
P=.014). For each 10 percentage
point increase in FTEs per capita,
CVD mortality declined by 0.65
percentage points.
For states that experienced an
increase in expenditures per cap-
ita, spending increased an average
of 24.7%, which would have
resulted in a decrease in infectious
disease morbidity by 4.50 per-
centage points—a 7.0% reduction
in infectious disease morbidity
that is associated with the increase
in LHD spending. For states that
showed an increase in FTEs per
capita, staffing increased an aver-
age of 21.4%, which would have
resulted in a decrease in CVD
mortality by 1.39 percentage
points—a 6.6% reduction in CVD
mortality associated with the in-
crease in LHD staffing.
DISCUSSION
The primary findings of this
study revealed that an increase in
LHD expenditures per capita was
associated with a decrease in in-
fectious disease morbidity at the
state level, and an increase in
FTEs per capita was associated
with a decrease in CVD deaths.
Although these results point to an
association between LHD inputs
and state health outcomes, the
mechanisms linking LHD ser-
vices or activities to such inputs
and outcomes can only be
inferred.
The finding of an association
between LHD expenditures and
improvements in infectious dis-
ease mortality is consistent with
cross-sectional studies that have
identified positive correlations
between absolute LHD expendi-
tures5,10,25 as well as expenditures
per capita8,12,14,26 with LHD per-
formance or effectiveness. Mays
and Smith provide the only evi-
dence to date that changes in
expenditures per capita are cor-
related with changes in health
outcomes, with the strongest as-
sociations between LHD spend-
ing and infant mortality and CVD
deaths; mortality from influenza
changed in the expected direction
but did not reach statistical sig-
nificance.18
The association between
changes in FTEs per capita and
changes in CVD deaths is consis-
tent with cross-sectional studies
that have found positive correla-
tions between the number of FTEs
and LHD performance and effec-
tiveness5,6,10,27 and with studies
that have specifically examined
FTEs per capita.8 None of these
studies measured longitudinal
changes in FTEs per capita, and no
study directly correlates FTEs per
capita with health outcomes.
If our results suggest that in-
creases in LHD inputs may con-
tribute to improvements in health
outcomes, then what are the pos-
sible pathways? In the 2005 Pro-
file of Local Health Departments,
TABLE 2—Changes in Dependent Variables From America’s Health Rankings Reports Between
1998 and 2008: 42 US States
Dependent Variable Mean Median SD Minimuma Maximumb IQR
Proportional change (%)
Smoking prevalence –14.58 –14.31 7.83 –29.41 4.87 11.95
Obesity prevalence 57.65 54.53 16.55 29.24 108.06 15.71
Infectious diseases –58.76 –57.68 17.47 –96.41 –29.23 25.05
Infant mortality –9.05 –10.13 10.87 –34.21 20.00 13.17
Cardiovascular disease deaths –17.72 –18.16 4.49 –28.25 –4.66 5.36
Cancer deaths –7.06 –7.17 –13.26 –13.26 2.22 5.45
Years of potential life lost –5.08 –4.86 8.29 –28.34 14.02 11.59
Absolute change
Smoking prevalence –3.41 –3.25 1.90 –7.70 1.20 2.20
Obesity prevalence 9.50 9.45 2.11 6.00 14.30 2.50
Infectious diseases –24.96 –21.02 16.60 –67.05 –4.79 26.30
Infant mortality –0.68 –0.80 0.83 –2.60 1.50 1.00
Cardiovascular disease deaths –62.83 –62.30 14.59 –100.70 –17.90 12.80
Cancer deaths –14.83 –14.26 7.67 –29.09 3.91 10.29
Years of potential life lost –385.80 –370.95 684.85 –2462.70 1160.40 806.70
Note. IQR = interquartile range.
aFor negative numbers, greatest decrease, 1998–2008.
bGreatest increase.
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NACCHO provided a comparison
between LHD activities reported
in the 1993 survey and responses
to similar questions in the 2005
survey.21 This comparison showed
an increase in communicable dis-
ease surveillance and epidemiolog-
ical investigations, which could
provide a pathway to a decrease in
infectious disease cases.
This may also link to the single
area for which there has been
a substantial increase in public
health resources over the past
several years: emergency pre-
paredness. Since 2001, the CDC
has provided $800 million to $1
billion annually to strengthen
public health infrastructure and
capacity to respond to public
health emergencies, including
bioterrorism.28 These funds are
provided for the most part through
cooperative agreements with
states, but there is good evidence
that such funding has made its
way to the local level. In 2005,
NACCHO reported that 73%
of LHDs were receiving public
health preparedness funds
through their state agencies, at an
average amount of $0.99 per
capita, for a median of $35000
per LHD.21 Fifty-one percent of
LHDs reported hiring additional
FTEs by using funding from the
CDC cooperative agreement.
The evidence supporting
a pathway between LHD inputs
and improvements in CVD deaths
that goes through LHD services or
activities is limited and indirect
at best. Cardiovascular diseases
remain the leading cause of death
in the United States, even though
overall heart disease death rates
have been declining since 1968.29
In a recent study exploring the
reasons for this decline, Ford et al.
determined that 47% of the decline
in the coronary heart disease death
rate was attributable to improved
medical therapies, and 44% of the
decline was attributable to risk fac-
tor modifications—including reduc-
tions in total cholesterol, systolic
blood pressure, smoking preva-
lence, and physical inactivity.30
Local health departments may
influence risk factor modifications
through clinical preventive ser-
vices as well as through popula-
tion-directed activities. A primary
risk factor for CVD is tobacco use,
and the NACCHO comparison of
LHD services and activities over
time shows that tobacco use pre-
vention activities increased; how-
ever, chronic disease surveillance
remained static, screening services
for high blood pressure and di-
abetes fell, and the provision of
comprehensive primary care de-
creased by more than 50%.21 If
the general movement away from
clinical service provision was met
with a concomitant increase in
population-focused activities—such
as through health assessment, plan-
ning, and policymaking—this may
provide a pathway between LHD
inputs and CVD mortality reduc-
tion. Although the evidence
base for community activities is
TABLE 3—Correlations of Changes in LHD Inputs (1997–2005) With Changes in Health Measures
(1998–2008), Using Values of Proportional and Absolute Change: 42 US States
Health Measures
LHD Inputs
Proportional Change Absolute Change
Expenditures per Capita FTEs per Capita, r (P) Expenditures per Capita, r (P) FTEs per Capita, r (P)
Smoking NS NS NS NS
Obesity NS NS NS NS
Infectious diseases NS NS –0.3407 (.027) NS
Infant mortality NS NS NS –0.2735 (.08)
Cardiovascular deaths NS –0.3482 (.024) –0.3723 (.015) –0.3689 (.016)
Cancer deaths NS NS NS NS
Years of potential life lost NS NS NS NS
Notes. FTE = full-time-equivalent employee; IQR = interquartile range; LHD = local health department; NS = not significant at P < .05. All
correlations calculated with the Spearman rank coefficient.
TABLE 4—Multiple Linear Regression Results for Changes in Infectious Diseases With Changes
in Expenditures per Capita, and for Changes in Cardiovascular Disease Deaths With Changes
in FTEs per Capita: 42 US States
Variable Coefficient (SE) 95% CI t P
Changes in infectious
diseases with changes in
expenditures per capitaa
–0.18226 (0.08384) –0.3524, –0.01206 –2.17 .037
Changes in cardiovascular
disease deaths with changes
in FTEs per capitab
–0.06504 (0.02515) –0.1161, –0.01398 –2.59 .014
Notes. CI = confidence interval; FTE = full-time-equivalent employee.
aAdjusted R2 = 0.3873; F6,35 = 5.32; P < .001.
bAdjusted R2 = 0.3612; F6,35 = 4.86; P = .001.
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improving,20 this study did not
attempt to explore such pathways.
There were no statistically sig-
nificant findings in the regression
models for the other health
measures—smoking and obesity
prevalence, infant mortality, cancer
mortality, and premature death.
These measures may be less ame-
nable to change with LHD inter-
ventions; the timeframe for detect-
ing change may have been too
short; there may be fewer LHD
services specifically addressing
these health measures; and there
may be no true effect of LHD
inputs on these health measures.
The preponderance of both bivar-
iate and multivariate analyses that
yielded nonsignificant results may
also be a reflection of low power
because of the relatively small
sample size (n=42 states).
Although there is a growing
body of literature that links LHD
inputs to performance,2 finding
any association between LHD in-
puts and health outcomes, whether
through cross-sectional or longitu-
dinal studies, has been a methodo-
logical challenge. Only recently,
with the ability to link repeated
measures of LHD inputs through
the NACCHO surveys, have inves-
tigators had access to data that
allow for such studies.
Limitations
There are several limitations to
this study and its findings. First,
the association of changes in LHD
inputs with changes in health out-
comes does not prove cause and
effect, and reverse causation, or
endogeneity, cannot be ruled out.
Second, we used proportional and
absolute change between 2 points
in time and did not consider the
changes that may have occurred
within the time period. Third,
there is a potential ecologic fallacy
in that the health outcome changes
that took place may have been
experienced by subpopulations
other than those represented by
the LHDs that were included in the
analyses. Fourth, the timeframe
covered by this study may be too
short to detect real associations
that may be detectable if studied
over a longer period.
Fifth, although statistically sig-
nificant, the coefficient for FTEs
per capita in the regression model
(–0.06504) indicates that the
expected percentage decrease in
CVD deaths given a 1 percentage
point increase in FTEs per capita is
relatively low. State and local
health departments are frequently
mandated by law to establish in-
fectious disease control programs,
whereas services to prevent or
treat CVDs are more frequently
optional. This creates a greater
sensitivity for health outcomes
that connect to activities for which
LHDs exert more control—thus,
there is a greater likelihood that
the association of changes in LHD
staffing and CVDs is spurious in
contrast to the stronger, more
robust association between LHD
spending and infectious diseases.
Sixth, this study did not consider
state and federal public health
spending that does not get in-
cluded in the LHD expenditures
measure, yet may still affect LHD
functions, performance, and
health outcomes.
Implications for Future Study
Our findings suggest at least 3
avenues for further study. First,
there is the opportunity to carry
out natural experiments, with the
results of this study forming
a baseline for later analyses. Since
2005, federal funding for state
and local preparedness has been
cut more than 25%, and states are
no longer receiving any supple-
mental funding for pandemic in-
fluenza preparedness.31 If expen-
ditures per capita are linked to
infectious disease morbidity
through activities previously sup-
ported by such funding, future
slowing of gains made—or even
a reversal in infectious disease
morbidity—may provide further
evidence of the association between
LHD inputs and health outcomes as
well as the possible pathway.
Second, exploring statewide
initiatives may help to explain the
pathway between LHD inputs and
health outcomes. It may be very
instructive to examine—through
documents and key informant
interviews—whether states that
improved in rankings and had in-
creases in public health expendi-
tures and FTEs implemented spe-
cific activities in response to early
AHR reports.
Third, repeating the methodol-
ogies in this study with earlier and
later NACCHO surveys will extend
the timeframe for studying changes
in LHD inputs and outputs.
Finally, all of these avenues for
further study would be greatly en-
hanced if LHDs used a consistent,
uniform chart of accounts, improv-
ing comparability. Collecting con-
sistent state-level data, using the
Association of State and Territorial
Health Officials’ 2009 State Public
Health Survey32 as a starting point,
will likewise be of great benefit to
future research in this field.
Conclusions
In keeping with what Turnock
and Handler have suggested, our
purpose was to ‘‘to measure [LHD]
inputs, processes, outputs, and
outcomes in ways that allow for
changes [emphasis added] in one
to be linked with another.’’33(p279)
Our findings suggest that improve-
ments in public health resources at
the local level may contribute to
improved health outcomes at the
state level. Although it was not
possible to identify changes in LHD
services or activities that could
provide a clear pathway between
inputs and outcomes, there are op-
portunities to use the findings from
this study to further strengthen
the empirical base for what LHDs
should be funded to do.j
About the Authors
Paul Campbell Erwin is with the Center for
Public Health, University of Tennessee,
Knoxville. Sandra B. Greene and Thomas
C. Ricketts are with the Gillings School of
Global Public Health, University of North
Carolina, Chapel Hill, and the Cecil G.
Sheps Center for Health Services Research,
University of North Carolina, Chapel Hill.
Glen P. Mays is with the Fay W. Boozman
College of Public Health, University of
Arkansas for Medical Sciences, Little Rock.
Mary V. Davis is with the North Carolina
Institute for Public Health, University of
North Carolina, Chapel Hill, and the Gil-
lings School of Global Public Health, Uni-
versity of North Carolina, Chapel Hill.
Correspondence should be sent to Paul
Campbell Erwin, MD, DrPH, Professor and
Director, Center for Public Health, Univer-
sity of Tennessee, 302 Bailey Education
Complex, Knoxville, TN 37996 (e-mail:
perwin@utk.edu). Reprints can be ordered
at http://www.ajph.org by clicking on the
‘‘Reprints/Eprints’’ link.
This article was accepted December 9,
2009.
Contributors
P. C. Erwin originated the study and led
the data analysis and writing. S. B. Greene
and M.V. Davis assisted with the study
614 | Government, Politics, and Law | Peer Reviewed | McAllister et al. American Journal of Public Health | April 2011, Vol 101, No. 4
GOVERNMENT, POLITICS, AND LAW
design and the writing. G. P. Mays and
T.C. Ricketts assisted with data analysis
and writing.
Acknowledgments
This research was supported by a mini-
grant from Assuring the Future of Public
Health Systems and Services Research,
a program of the University of Kentucky
Center for Public Health Systems and
Services Research, funded by the Robert
Wood Johnson Foundation (grant
3049022733-08-505).
The authors wish to acknowledge
Edward Brooks for reviewing and com-
menting on earlier versions of this article,
the National Association of County and
City Health Officials and the United Health
Foundation for providing data used in this
study, and Mary F. Evans for technical
assistance in data management.
Human Participant Protection
This study made use of secondary data
only, available to the public, and did not
require institutional review board approval
through the University of Tennessee.
References
1. Institute of Medicine. The Future of
Public Health. Washington, DC: National
Academy Press; 1988.
2. Erwin PC. The performance of local
health departments: a review of the liter-
ature. J Public Health Manag Pract. 2008;
14(2):E9–E18.
3. Turnock BJ, Handler A, Hall W, et al.
Local health department effectiveness in
addressing the core functions of public
health. Public Health Rep. 1994;109(5):
653–658.
4. Suen JC, Christenson GM, Nicola RM.
The key role of nurses in local health
departments. Am J Public Health. 1995;
85(1):120–121.
5. Handler AS, Turnock BJ. Local health
department effectiveness in addressing
the core functions of public health:
essential ingredients. J Public Health
Policy. 1996;17(4):460–483.
6. Mayer JP, Konstant L, Wartman GC.
Typology of local health departments
based on maternal and child health core
functions. J Public Health Manag Pract.
1997;3(5):1–10.
7. Turnock BJ, Handler A, Miller CA.
Core function-related local public health
practice effectiveness. J Public Health
Manag Pract. 1998;4(5):26–32.
8. Freund CG, Liu Z. Local health de-
partment capacity and performance in
New Jersey. J Public Health Manag Pract.
2000;6(5):42–50.
9. Kennedy VC. A study of local public
health system performance in Texas. J
Public Health Manag Pract. 2003;9(3):
183–187.
10. Mauer BJ, Mason M, Brown B.
Application of quality measurement and
performance standards to public health
systems: Washington State’s approach. J
Public Health Manag Pract. 2004;10(4):
330–337.
11. Scutchfield FD, Knight EA, Kelly AV,
Bhandari MW, Vasilescu IP. Local public
health agency capacity and its relationship
to public health system performance. J
Public Health Manag Pract. 2004;10(3):
204–215.
12. Mays GP, McHugh MC, Shim K, et al.
Getting what you pay for: public health
spending and the performance of essen-
tial public health services. J Public Health
Manag Pract. 2004;10(5):435–443.
13. Honore PA, Simoes EJ, Jones WJ,
Moonesinghe R. Practices in public health
finance: an investigation of jurisdiction
funding patterns and performance. J Pub-
lic Health Manag Pract. 2004;10(5):444–
450.
14. Mays GP, Halverson PK, Baker EL,
Stevens R, Vann JJ. Availability and per-
ceived effectiveness of public health ac-
tivities in the nation’s most populous
communities. Am J Public Health. 2004;
94(6):1019–1026.
15. Lovelace K. Multidisciplinary top
management teamwork: effects on local
health department performance. J Pub-
lic Health Manag Pract. 2001;7(1):21–
29.
16. Schenck SE, Miller CA, Richards TB.
Public health performance related to se-
lected health status and risk measures.
Am J Prev Med. 1995;11(6 suppl):55–57.
17. Kanarek N, Stanley J, Bialek R. Local
public health agency performance and
community health status. J Public Health
Manag Pract. 2006;12(6):522–527.
18. Mays GP, Smith SA. Effects of local
public health spending on population
health: does more money matter? Health
Serv Res. In press.
19. Handler A, Issel M, Turnock B. A
conceptual framework to measure per-
formance of the public health system. Am
J Public Health. 2001;91(8):1235–1239.
20. Zaza S, Briss PA, Harris KW, eds. The
Guide to Community Preventive Services.
New York, NY: Oxford University Press
Inc; 2005.
21. 2005 National Profile of Local Health
Departments. Washington, DC: National
Association of County and City Health
Officials; 2006.
22. United Health Foundation. America’s
Health Rankings: A call to action for people
and communities. Available at: http://www.
unitedhealthfoundation.org/ahr2007/
index.html. Accessed January 31, 2008.
23. Centers for Disease Control and
Prevention. Behavioral Risk Factor Sur-
veillance System. Available at: http://
cdc.gov/brfss. Accessed February 16,
2007.
24. National Center for Health Statistics,
Centers for Disease Control and Preven-
tion. National Vital Statistics System.
Available at: http://www.cdc.gov/nchs/
nvss.htm. Accessed March 1, 2008.
25. Suen J, Christenson GM, Cooper A,
Taylor M. Analysis of the current status of
public health practice in local health
departments. Am J Prev Med. 1995;11(6
suppl):51–54.
26. Mays GP, McHugh MC, Shim K,
et al. Institutional and economic deter-
minants of public health system perfor-
mance. Am J Public Health.
2006;96(3):523–531.
27. Zahner SJ, Vandermause R. Local
health department performance: com-
pliance with state statutes and rules. J
Public Health Manag Pract.
2003;9(1):25–34.
28. Public Health Emergency Pre-
paredness Partners. Public health
emergency preparedness: six years of
achievement. Available at: http://
www.aphl.org/aphlprograms/ep/ahr/
Documents/PHEP_Partners_Report.pdf.
Accessed April 18, 2010.
29. Lloyd-Jones D, Adams R, Carnethon
M, et al. for the American Heart Associa-
tion Statistics Committee and Stroke Sta-
tistics Subcommittee. Heart disease and
stroke statistics–2009 update. A report
from the American Heart Association
Statistics Committee and Stroke Statistics
Subcommittee. Circulation. 2009;119(3):
480–486.
30. Ford ES, Ajani UA, Croft JB, et al.
Explaining the decrease in US deaths
from coronary disease, 1980-2000. N
Engl J Med. 2007;356(23):2388–
2398.
31. Trust for America’s Health. Ready or
not? Protecting the public’s health from




32. Association of State and Territorial
Health Officials. State Public Health Sur-
vey. Available at: http://www.astho.org/
research/data-and-analysis. Accessed Oc-
tober 13, 2009.
33. Turnock BJ, Handler AS. From
measuring to improving public health
practice. Annu Rev Public Health. 1997;
18:261–282.
April 2011, Vol 101, No. 4 | American Journal of Public Health Erwin et al. | Peer Reviewed | Government, Politics, and Law | 615
GOVERNMENT, POLITICS, AND LAW
